Oscar Health (NYSE:OSCR) Trading Up 10.9% - Still a Buy?

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) were up 10.9% on Thursday . The stock traded as high as $20.99 and last traded at $21.28. Approximately 4,535,521 shares were traded during trading, a decline of 20% from the average daily volume of 5,649,624 shares. The stock had previously closed at $19.19.

Analyst Ratings Changes

A number of research firms have issued reports on OSCR. Wall Street Zen cut Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday. Finally, Piper Sandler cut their price target on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research note on Monday, June 9th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $16.50.

Oscar Health Trading Up 6.7%

The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $5.22 billion, a P/E ratio of 73.16 and a beta of 1.73. The business has a fifty day moving average price of $15.04 and a 200 day moving average price of $14.58.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. Oscar Health's revenue for the quarter was up 42.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.62 EPS. On average, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director now owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Southeastern Asset Management Inc. TN boosted its holdings in shares of Oscar Health by 52.2% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after buying an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its stake in shares of Oscar Health by 37.8% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after purchasing an additional 477,634 shares during the last quarter. Man Group plc raised its holdings in shares of Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the period. Toronto Dominion Bank bought a new stake in shares of Oscar Health in the 4th quarter valued at about $1,008,000. Finally, Lingotto Investment Management LLP acquired a new stake in Oscar Health in the 4th quarter valued at about $2,543,000. 75.70% of the stock is currently owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.